Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Study acronym: GP
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv23
  2. Study Status, Outcome Measuresv22
  3. Site contact updatedv21
  4. Primary and study completion dates: Jul 2025 to Jul 2035
    • Site contact updated
    v20
  5. Trial status: Active, Not Recruiting to Recruiting
    • Study description expanded, about 65 words
    • Site details revised
    v19
Show 17 earlier versionsHide 17 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v18
  2. 2 versions Re-verified since Sep 15, 2020, no change to tracked fieldsv16-v17
  3. Primary and study completion dates: Jul 2020 to Jul 2025v15
  4. 2 versions Re-verified since Jul 24, 2017, no change to tracked fieldsv13-v14
  5. Site contact updatedv12
  6. Enrollment target: 1000 to 2000
    • Primary and study completion dates: Jul 2015 to Jul 2020
    • Site contact updated
    v11
  7. Eligibility criteria revisedv10
  8. Primary completion date: Jul 2015
    • Study completion date: Jul 2010 to Jul 2015
    • Eligibility criteria expanded, about 6 words
    • Site contact updated
    v9
  9. Re-verified, no change to tracked fieldsv8
  10. Enrollment target: 300 to 1000v7
  11. Study completion date: Apr 2007 to Jul 2010
    • Site contact updated
    • Eligibility criteria expanded, about 3 words
    v6
  12. Study completion date: Apr 2007
    • Site contact updated
    v5
  13. Site contact updatedv4
  14. Re-verified, no change to tracked fieldsv3
  15. Eligibility criteria shortened, about 1 word
    • Study description expanded, about 1 word
    • Study title expanded, about 3 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Trial Details
NCT Number NCT00258570
Lead Sponsor University of Pittsburgh
Conditions
(from sponsor)		 Pulmonary Fibrosis
Related terms Pulmonary Fibrosis
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov